# Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight Infants

> **NCT01400737** · NA · UNKNOWN · sponsor: **Zekai Tahir Burak Women's Health Research and Education Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Oral Ibuprofen Prophylaxis in Very Low Birth Weight Infants

## Interventions

- **DRUG:** ibuprofen
- **DRUG:** ibuprofen

## Key facts

- **NCT ID:** NCT01400737
- **Lead sponsor:** Zekai Tahir Burak Women's Health Research and Education Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01400737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01400737, "Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight Infants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01400737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*